Kazia Therapeutics Limited ADR [NASDAQ: KZIA] slipped around -0.32 points on Tuesday, while shares priced at $5.76 at the close of the session, down -5.29%.
Kazia Therapeutics Limited ADR stock is now -78.14% down from its year-to-date (YTD) trading value. KZIA Stock saw the intraday high of $6.0 and lowest of $5.5787 per share. The company’s 52-week high price is 30.05, which means current price is +101.40% above from all time high which was touched on 01/30/25.
Compared to the average trading volume of 124.73K shares, KZIA reached a trading volume of 3168839 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Kazia Therapeutics Limited ADR [KZIA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for KZIA shares is $16.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on KZIA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Kazia Therapeutics Limited ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 06, 2025. While these analysts kept the previous recommendation, Maxim Group raised their target price to Buy. The new note on the price target was released on October 14, 2021, representing the official price target for Kazia Therapeutics Limited ADR stock. Previously, the target price had yet another raise to $17, while H.C. Wainwright analysts kept a Buy rating on KZIA stock.
How has KZIA stock performed recently?
Kazia Therapeutics Limited ADR [KZIA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -24.80. With this latest performance, KZIA shares dropped by -22.06% in over the last four-week period, additionally plugging by 62.71% over the last 6 months – not to mention a drop of -34.92% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for KZIA stock in for the last two-week period is set at 28.11, with the RSI for the last a single of trading hit 0.55, and the three-weeks RSI is set at 0.53 for Kazia Therapeutics Limited ADR [KZIA]. The present Moving Average for the last 50 days of trading for this stock 7.29, while it was recorded at 6.60 for the last single week of trading, and 6.29 for the last 200 days.
Kazia Therapeutics Limited ADR [KZIA]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Kazia Therapeutics Limited ADR [KZIA] shares currently have an operating margin of -39043.54%. Kazia Therapeutics Limited ADR’s Net Margin is presently recorded at -50335.51%.
Kazia Therapeutics Limited ADR (KZIA) Capital Structure & Debt Analysis
Kazia Therapeutics Limited ADR (KZIA) Efficiency & Liquidity Metrics
Kazia Therapeutics Limited ADR (KZIA) Efficiency & Liquidity Metrics
Earnings analysis for Kazia Therapeutics Limited ADR [KZIA]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for KZIA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Kazia Therapeutics Limited ADR go to 24.88%.
Insider trade positions for Kazia Therapeutics Limited ADR [KZIA]
There are presently around $11.18%, or 12.27%% of KZIA stock, in the hands of institutional investors. The top three institutional holders of KZIA stocks are: BNP PARIBAS ARBITRAGE, SNC with ownership of 63568.0 shares, which is approximately 0.2651%. SUSQUEHANNA INTERNATIONAL GROUP, LLP, holding 41478.0 shares of the stock with an approximate value of $$9457.0 in KZIA stocks shares; and SUSQUEHANNA INTERNATIONAL GROUP, LLP, currently with $$9000.0 in KZIA stock with ownership which is approximately 0.1638%.
